Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Arq. bras. cardiol ; 108(3): 237-245, Mar. 2017. graf
Article in English | LILACS | ID: biblio-838708

ABSTRACT

Abstract Background: Radiofrequency ablation of renal sympathetic nerve (RDN) shows effective BP reduction in hypertensive patients while the specific mechanisms remain unclear. Objective: We hypothesized that abnormal levels of norepinephrine (NE) and changes in NE-related enzymes and angiotensinconverting enzyme 2 (ACE2), angiotensin (Ang)-(1-7) and Mas receptor mediate the anti-hypertensive effects of RDN. Methods: Mean values of systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP) were assessed at baseline and follow-up. Plasma and renal norepinephrine (NE) concentrations were determined using highperformance liquid chromatography with electrochemical detection, and levels of NE-related enzyme and ACE2-Ang(1-7)- Mas were measured using real time PCR, Western blot and immunohistochemistry or Elisa in a hypertensive canine model fed with high-fat diet and treated with RDN. The parameters were also determined in a sham group treated with renal arteriography and a control group fed with normal diet. Results: RDN decreased SBP, DBP, MAP, plasma and renal NE. Compared with the sham group, renal tyrosine hydroxylase (TH) expression was lower and renalase expression was higher in the RDN group. Compared with the control group, renal TH and catechol-o-methyl transferase (COMT) were higher and renalase was lower in the sham group. Moreover, renal ACE2, Ang-(1-7) and Mas levels of the RDN group were higher than those of the sham group, which were lower than those of the control group. Conclusion: RDN shows anti-hypertensive effect with reduced NE and activation of ACE2-Ang(1-7)-Mas, indicating that it may contribute to the anti-hypertensive effect of RDN.


Resumo Fundamentos: A denervação simpática renal por radiofrequência (DSR) mostra redução eficaz da pressão arterial (PA) de pacientes hipertensos, ainda que os mecanismos específicos permaneçam obscuros. Objetivo: Fizemos a hipótese de que níveis alterados de noradrenalina (NA) e mudanças nas enzimas relacionadas à NA e enzima conversora de angiotensina 2 (ECA-2), angiotensina (Ang)-(1-7) e receptor Mas são mediadores dos efeitos antihipertensivos da DSR. Métodos: Foram avaliados os valores médios de pressão arterial sistólica (PAS), pressão arterial diastólica (PAD) e pressão arterial média (PAM) no início e durante o seguimento. Foram medidas as concentrações plasmática e renal de noradrenalina (NA) por cromatografia líquida de alta eficiência com detecção eletroquímica, e os níveis de enzima relacionada à NA e ECA2-Ang-(1-7)-Mas através de PCR em tempo real, Western blot e imunohistoquímica ou Elisa em um modelo canino de hipertensão que recebeu ração rica em gordura e foi tratado com DSR. Os parâmetros também foram determinados em um grupo de cirurgia simulada submetido à arteriografia renal e em um grupo controle que recebeu dieta normal. Resultados: DSR causou diminuição da PAS, PAD, PAM e das concentrações plasmática e renal de NA. Em comparação ao grupo placebo, a expressão da tirosina hidroxilase (TH) renal foi menor e a da renalase foi maior no grupo DSR. Em comparação ao grupo controle, os níveis de TH renal e de catecol-o-metil-transferase (COMT) foram maiores e os de renalase foram menores no grupo cirurgia simulada. Além disso, os níveis renais de ECA2, Ang-(1-7) e Mas foram maiores no grupo DSR do que no grupo cirurgia simulada, que, por sua vez, foram menores do que no grupo controle. Conclusões: A DSR mostra efeitos anti-hipertensivos com redução da NA e ativação da ECA2-Ang-(1-7)-Mas, o que indica que pode contribuir com o efeito anti-hipertensivo da DSR.


Subject(s)
Animals , Dogs , Sympathectomy/methods , Catheter Ablation/methods , Hypertension/surgery , Kidney/surgery , Kidney/innervation , Peptide Fragments/analysis , Reference Values , Renal Artery/surgery , Tyrosine 3-Monooxygenase/analysis , Body Weight , Angiotensin I/analysis , Immunohistochemistry , Random Allocation , Catechol O-Methyltransferase/analysis , Blotting, Western , Reproducibility of Results , Chromatography, High Pressure Liquid , Treatment Outcome , Peptidyl-Dipeptidase A/analysis , Models, Animal , Norepinephrine Plasma Membrane Transport Proteins/analysis , Diet, High-Fat , Monoamine Oxidase/analysis
2.
Journal of Korean Medical Science ; : 171-177, 2016.
Article in English | WPRIM | ID: wpr-133743

ABSTRACT

We investigated the potential of human dental pulp stem cells (hDPSCs) to differentiate into dopaminergic neurons in vitro as an autologous stem cell source for Parkinson's disease treatment. The hDPSCs were expanded in knockout-embryonic stem cell (KO-ES) medium containing leukemia inhibitory factor (LIF) on gelatin-coated plates for 3-4 days. Then, the medium was replaced with KO-ES medium without LIF to allow the formation of the neurosphere for 4 days. The neurosphere was transferred into ITS medium, containing ITS (human insulin-transferrin-sodium) and fibronectin, to select for Nestin-positive cells for 6-8 days. The cells were then cultured in N-2 medium containing basic fibroblast growth factor (FGF), FGF-8b, sonic hedgehog-N, and ascorbic acid on poly-l-ornithine/fibronectin-coated plates to expand the Nestin-positive cells for up to 2 weeks. Finally, the cells were transferred into N-2/ascorbic acid medium to allow for their differentiation into dopaminergic neurons for 10-15 days. The differentiation stages were confirmed by morphological, immunocytochemical, flow cytometric, real-time PCR, and ELISA analyses. The expressions of mesenchymal stem cell markers were observed at the early stages. The expressions of early neuronal markers were maintained throughout the differentiation stages. The mature neural markers showed increased expression from stage 3 onwards. The percentage of cells positive for tyrosine hydroxylase was 14.49%, and the amount was 0.526 ± 0.033 ng/mL at the last stage. hDPSCs can differentiate into dopaminergic neural cells under experimental cell differentiation conditions, showing potential as an autologous cell source for the treatment of Parkinson's disease.


Subject(s)
Animals , Humans , Mice , Brain/pathology , Cell Differentiation/drug effects , Cells, Cultured , Culture Media/chemistry , Dental Pulp/cytology , Dopaminergic Neurons/cytology , Enzyme-Linked Immunosorbent Assay , Glial Fibrillary Acidic Protein/genetics , Mice, Inbred ICR , Myelin Basic Protein/genetics , Real-Time Polymerase Chain Reaction , Stage-Specific Embryonic Antigens/genetics , Stem Cells/cytology , Tubulin/genetics , Tyrosine 3-Monooxygenase/analysis
3.
Journal of Korean Medical Science ; : 171-177, 2016.
Article in English | WPRIM | ID: wpr-133742

ABSTRACT

We investigated the potential of human dental pulp stem cells (hDPSCs) to differentiate into dopaminergic neurons in vitro as an autologous stem cell source for Parkinson's disease treatment. The hDPSCs were expanded in knockout-embryonic stem cell (KO-ES) medium containing leukemia inhibitory factor (LIF) on gelatin-coated plates for 3-4 days. Then, the medium was replaced with KO-ES medium without LIF to allow the formation of the neurosphere for 4 days. The neurosphere was transferred into ITS medium, containing ITS (human insulin-transferrin-sodium) and fibronectin, to select for Nestin-positive cells for 6-8 days. The cells were then cultured in N-2 medium containing basic fibroblast growth factor (FGF), FGF-8b, sonic hedgehog-N, and ascorbic acid on poly-l-ornithine/fibronectin-coated plates to expand the Nestin-positive cells for up to 2 weeks. Finally, the cells were transferred into N-2/ascorbic acid medium to allow for their differentiation into dopaminergic neurons for 10-15 days. The differentiation stages were confirmed by morphological, immunocytochemical, flow cytometric, real-time PCR, and ELISA analyses. The expressions of mesenchymal stem cell markers were observed at the early stages. The expressions of early neuronal markers were maintained throughout the differentiation stages. The mature neural markers showed increased expression from stage 3 onwards. The percentage of cells positive for tyrosine hydroxylase was 14.49%, and the amount was 0.526 ± 0.033 ng/mL at the last stage. hDPSCs can differentiate into dopaminergic neural cells under experimental cell differentiation conditions, showing potential as an autologous cell source for the treatment of Parkinson's disease.


Subject(s)
Animals , Humans , Mice , Brain/pathology , Cell Differentiation/drug effects , Cells, Cultured , Culture Media/chemistry , Dental Pulp/cytology , Dopaminergic Neurons/cytology , Enzyme-Linked Immunosorbent Assay , Glial Fibrillary Acidic Protein/genetics , Mice, Inbred ICR , Myelin Basic Protein/genetics , Real-Time Polymerase Chain Reaction , Stage-Specific Embryonic Antigens/genetics , Stem Cells/cytology , Tubulin/genetics , Tyrosine 3-Monooxygenase/analysis
4.
Experimental & Molecular Medicine ; : e118-2014.
Article in English | WPRIM | ID: wpr-222038

ABSTRACT

This study assessed the roles of chronic stress (CS) in the stimulation of the sympathetic nervous system and explored the underlying mechanisms of periodontitis. Using an animal model of periodontitis and CS, the expression of tyrosine hydroxylase (TH) and the protein levels of the alpha1-adrenergic receptor (alpha1-AR) and beta2-adrenergic receptor (beta2-AR) were assessed. Furthermore, human periodontal ligament fibroblasts (HPDLFs) were stimulated with lipopolysaccharide (LPS) to mimic the process of inflammation. The proliferation of the HPDLFs and the expression of alpha1-AR and beta2-AR were assessed. The inflammatory-related cytokines interleukin (IL)-1beta, IL-6 and IL-8 were detected after pretreatment with the alpha1/beta2-AR blockers phentolamine/propranolol, both in vitro and in vivo. Results show that periodontitis under CS conditions enhanced the expression of TH, alpha1-AR and beta2-AR. Phentolamine significantly reduced the inflammatory cytokine levels. Furthermore, we observed a marked decrease in HPDLF proliferation and the increased expression of alpha1-ARfollowing LPS pretreatment. Pretreatment with phentolamine dramatically ameliorated LPS-inhibited cell proliferation. In addition, the blocking of alpha1-ARsignaling also hindered the upregulation of the inflammatory-related cytokines IL-1beta, IL-6 and IL-8. These results suggest that CS can significantly enhance the pathological progression of periodontitis by an alpha1-adrenergic signaling-mediated inflammatory response. We have identified a potential therapeutic target for the treatment of periodontal disease, particularly in those patients suffering from concurrent CS.


Subject(s)
Animals , Humans , Male , Rats , Adrenergic alpha-1 Receptor Antagonists/therapeutic use , Cells, Cultured , Cytokines/immunology , Fibroblasts/immunology , Lipopolysaccharides/administration & dosage , Periodontal Ligament/cytology , Periodontitis/drug therapy , Phentolamine/therapeutic use , Rats, Wistar , Receptors, Adrenergic, alpha-1/analysis , Signal Transduction/drug effects , Stress, Physiological/drug effects , Tyrosine 3-Monooxygenase/analysis
5.
Folha méd ; 110(1): 115-8, jan.-fev. 1995. ilus, tab
Article in Portuguese | LILACS | ID: lil-154035

ABSTRACT

Os efeitos da administraçäo crônica do mazindol (5 e 10 mg/kg i.p. e 60 mg/kg s.c) sobre a evoluçäo ponderal e a atividade da tirosina hidroxilase cerebral foram determinados em ratos machos jovens e idosos. O potencial anorético da droga foi observado através da avaliaçäo comparativa do peso corporal dos animais. A atividade da tirosina hidroxilase no estriato foi utilizada como parâmetro indireto da possível neurotoxicidade do mazindol. Nos ratos jovens notou-se uma perda significativa de peso aos 15 dias de tratamento, com recuperaçäo ascendente deste ao longo do tempo. Nos ratos idosos houve também perda de peso significativa; no entanto, tal recuperaçäo näo foi observada. Näo foram detectadas alteraçöes significativas da atividade enzimática em relaçäo aos grupos controles para ambas as idades. Estes resultados säo analisados a partir de dados encontrados na literatura


Subject(s)
Animals , Male , Rats , Corpus Striatum/drug effects , Mazindol/toxicity , Cerebrum/drug effects , Methamphetamine/toxicity , Rats, Inbred Strains , Nerve Endings , Tyrosine 3-Monooxygenase/analysis , Weight Loss/drug effects
6.
P. R. health sci. j ; 12(2): 143-6, jun. 1993.
Article in English | LILACS | ID: lil-176753

ABSTRACT

Tyrosine hydroxylase (TH), the rate limiting enzyme in the conversion of tyrosine to DOPA, is a reliable marker for catecholaminergic (dopaminergic) neurons. To investigate the distribution of dopamine in the retina of the thirteen-lined ground squirrel (Spermophilus tridecemlineatus), retinal sections and wholemounts were incubated with an antiserum directed against TH and then processed using the avidin-biotin immunohistochemical method. TH-like immunoreactivity was exhibited by amacrine and interplexiform-like cells in the innermost portion of the inner nuclear layer (INL) and by cells we presume to be displaced amacrines in the ganglion cell layer (GCL). Their somata were 12 to 20 microns in diameter, with the majority measuring approximately 18 microns. In transverse sections the processes of the three types of neurons were seen to extend into lamina 1 of the inner plexiform layer (IPL). In horizontal sections 2-3 primary dendrites were seen to ramify and the branches extended for considerable distances, with overlap between the dendritic fields of neighboring TH cells. A distance to the nearest neighbor analysis suggests the TH-neurons in the INL are distributed in a non-random fashion


Subject(s)
Animals , Retinal Ganglion Cells/cytology , Retina/cytology , Sciuridae/anatomy & histology , Tyrosine 3-Monooxygenase/analysis , Retinal Ganglion Cells/chemistry , Retinal Ganglion Cells/metabolism , Retina/chemistry , Retina/metabolism , Sciuridae/metabolism , Tyrosine 3-Monooxygenase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL